Abstract: Hyperglycaemia is prevalent in critical care, and tight control can reduce mortality by 29 -45%. Targeted glucose control can be achieved by frequent fitting and prediction of a modelled insulin sensitivity index, S I . This parameter varies significantly in the critically ill due to condition evolution and drug therapies. A 3-D stochastic model of hourly S I variability is constructed using retrospective data from 18 long term critical care patients. The model can be used to produce the blood glucose level probability distribution one hour following a known insulin and/or nutrition intervention. Thus, it enables accurate prediction for glycemic control based on confidence intervals.
Introduction
Hyperglycemia and severe insulin resistance are prevalent in the critically ill, even given no history of diabetes [1] [2] [3] . Tight glucose control has been shown to reduce Intensive Care Unit (ICU) patient mortality by up to 45% [1] [2] [3] . Therefore, tight regulation glycemic control algorithms in the ICU would reduce mortality and the burden on time and medical resources.
Previous clinical glycemic control studies [4] focused on critical care patients, whose glucose-insulin dynamics are highly variable due to the stress from their condition and the impact of drug therapies. Chase et al. [4] developed a control algorithm that has been clinically verified in the ICU to predicatively reduce hyperglycaemic levels, while accounting for interpatient variability and evolving physiological condition. The overall approach is a targeted adaptive control scheme that identifies patient dynamics, particularly with respect to insulin sensitivity.
Following Chase et al. [4] , better understanding and modelling of patient variability in the ICU can lead to better glycemic management. In particular, a common risk in intensive insulin therapies in the ICU, is hypoglycemic events [1, 5] . Understanding and modelling the variability in patient condition, or more specifically, the patients' variable dynamic response to insulin, will thus assist clinical control intervention decision making, and minimise the associated risk.
Therefore, the ultimate goal of this study is to produce blood glucose confidence bands for control intervention decisions based on stochastic models of clinically observed parameter variations. These bands allow targeted control with user specified confidence on the outcome. The result will be added certainty and safety in glycemic control.
Glucose-Insulin System Model
This study uses a patient-specific, two-compartment glucose-insulin system model from Chase et al. [4] and Hann et al. [6] . This physiologically verified model, which captures the fundamental dynamic responses to elevated glycemic levels and insulin, accounts for timevarying insulin sensitivity and endogenous glucose removal, along with two different saturation kinetics.
where G and I denote the glucose above an equilibrium level, G E , and the plasma insulin from an exogenous insulin input respectively. Insulin utilization over time is Q, where k is the effective insulin decay rate. Patient endogenous glucose removal and insulin sensitivity are p G and S I . Insulin distribution volume is V I and n represents plasma insulin decay. External nutrition and insulin input are P(t) and u ex (t). Michaelis-Menten saturation in plasma insulin disappearance and insulinstimulated glucose removal are defined by α I and α G .
Insulin sensitivity, S I , is the critical parameter that drives the dynamics of the system. It represents the tissue insulin sensitivity, and its variation shows the evolution of patient condition and drug therapy. Identifying S I and its changes over time is thus critical to providing safe and effective tight glycemic control in the highly variable critical care population.
Integral-Based Parameter Identification
Using generic values for α G , α I , n, k and V I limits the model unknowns to p G and S I , as shown in Equations (1)-(3). An integration-based parameter identification method presented in Hann et al. [6] is used for accurate identification of patient specific parameters, p G and S I .
The functions for p G and S I can be arbitrarily defined. The integral-based method presents a convex least squares problem that demands little computational effort. In contrast, the commonly used non-linear recursive least squares routine is non-convex and starting point dependent [7] . Details of the fitting routine are outlined in Hann et al. [6] .
Stochastic Modelling
Patient parameters, p G and S I are fitted to long term retrospective clinical data from 18 patients in the Department of Intensive Care Medicine, Christchurch Hospital. These patients are a random selection from a 201-patients data audit [8] . Each patient record spans at least one day with data every three-hours or less. This cohort broadly represents the cross section of patients seen in the ICU, regarding medical condition, age, sex, APACHE II scores and mortality. Diabetic patients are somewhat over-represented as they receive greater attention in blood glucose levels.
Zero order piecewise linear functions are used to define p G and S I , with a discontinuity every two hours for p G and every hour for S I . Greater variability is given to S I because studies have shown that S I is much more variable than p G [6] . Table 1 shows the values used for the generic parameters based on various studies [9] [10] [11] . The fitted long term p G and S I data reveals that the variability of both parameters is dependent on its present value. The distribution of fitted S I is shown by the dots in Figure 1 . The probability distribution of potential S I , shown by the probability bands, clearly varies with its value across the horizontal axis. Figure 1 . Fitted S I and probability intervals Thus, the variations in S I can be treated as a Markov process. A Markov process has the property that the conditional probability distribution of future states of the process, given the present state, depends only upon the current state. Therefore, using the Markov property of the stochastic behaviour of S I , the conditional probability distribution of S I n+1 taking on a value y can be calculated by knowing S I n = x:
Considering the fitted S I in a 2-D space, as shown in Figure 1 , the joint probability function across the x-y (S I n -S I n+1 ) plane is defined by the fitted values shown by the dots whose coordinates are x i and y i , Effectively, the 2-D joint probability function is the normalised summation of normal probability distribution functions ) , ; ( To illustrate a 3-D map in the mind, consider this numerical operation as a sand building exercise. If the first quadrant of the x-y (S I n -S I n+1 ) plane, as shown in Figure 1 , is where the sand box is confined in, and that a pile of sand of a cubic unit is dropped onto every dot in Figure 1 , then the resulted sand sculpture is the simple representation of the joint probability P(x, y) on the x-y (S I n -S I n+1 ) plane. In Equations (5)-(7), the variance σ at each data point is a function of the local data density in a centred and orthonormalised space of x and y. Putting Equations (6) and (7) into Equation (5) In Equation (4), the denominator in the right hand side can be calculated by integrating Equation (5) with respect to y. Hence, Equation (5) Thus, knowing S I n = x at hour n, the probability of S I n+1 = y at hour n+1 can be calculated using Equations (8) and (9) . The probability intervals shown in Figure 1 are also calculated from integrating Equation (8). inter-quartile probability interval 0.90 probability interval raw fitted SI most probable S I forecast 0.95 probability interval
Plotting Equation (8) across the x-y (S I n -S I n+1 ) plane, the 3-D stochastic model is shown in Figure 2 .
Figure 2. Three-dimensional S I stochastic model
The same numerical operations described in Equations (4)- (9) also apply to p G , producing similar results. However the probability density across the x-y plane is highly concentrated along the line y = x. This result reinforces the idea that p G is effectively constant, even though patient specific [6] . Hence, variability of p G is neglected in this study.
The stochastic parameter model can be integrated into the glucose-insulin system model of Equations (1)- (3). This step allows the blood glucose level probability distribution one hour following a known insulin and/or nutrition intervention to be defined. The stochastic model therefore enables more knowledgeable predictions with defined probability distributions for the outcomes of glycemic control inputs.
Validation on Clinical Control Trials
The stochastic model developed from the 18-patients cohort in Hann et al. [6] is evaluated on 8 previous clinical control trials in the ICU [12] that are independent from the cohort used to develop the stochastic model. The trials performed consist of hourly cycles of the following steps [12]:
1. Measure blood glucose levels. 2. Fit p G and S I to the measured blood glucose. 3. Determine new control intervention to achieve a blood glucose target level. 4. Implement control intervention.
To asses the stochastic model, these 8 trials are numerically re-enacted with control interventions as given in the trial and step 3 of the trial cycle modified to:
3a. Generate potential S I probability intervals from the time-average identified S I of the fitted time interval using the stochastic model. 3b. Calculate blood glucose confidence intervals with respect to the S I probability intervals using the numerical model in Equations (1)- (3).
This test allows validation of the model in a clinical control scenario.
Clinical Trial Review Results ad Discussion
Blood glucose probability intervals were produced at each control intervention in the 8 clinical trials and compared to measured blood glucose levels one hour later. The results are shown in Table 2 . Detailed result from Trial 4 is shown Figure 4 . The simulated control aimed to maintain the glycemic levels close to but above 4 mmol/L. More aggressive interventions were issued in the first half of the simulated trial, achieving more tightly controlled glycemic levels. The brief blood glucose excursion below 4 mmol/L was still unavoidable because the S I variation exceeded the 0.90 confidence limit of the stochastic model. A more vigorous remedy action was taken at 360 minutes in the simulated trial to obtain a 0.90 confidence in blood glucose above 4 mmol/L in an hour. Overall, the S I stochastic model can deliver tighter and safer glycemic management and improve control intervention selection.
Across the 8 patients, the S I stochastic model successfully captures the identified S I variation trend, accounting for 94% of measurements over time within the 0.90 confidence band, and 73% with a 0.50 confidence. Hence, the model may be slightly conservative, which is safe in control.
When S I increases, the blood glucose level probability interval tightens. The wide range of uncertainties in blood glucose levels associated with low S I reflects the risk of insulin resistant patients under intensive insulin therapy encountering hypoglycaemia [5] . This situation was specifically seen in Patient 4, whose identified S I profile is in the lower physiological range.
Conclusions
The stochastic model presented defines the distribution of blood glucose levels one hour following a known insulin and/or nutrition intervention. It thus enables more knowledgeable and accurate prediction for glycemic control. The stochastic model acts as a tool to assist clinical intervention decisions, maximising the probability of achieving desired glycemic regulation while maintaining patient safety. The impact of control inputs on probabilistic blood glucose results can be assessed, giving confidence in the effectiveness of the control protocol against evolving patient dynamics. 
